This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Oct;13(4):207-18.

doi: 10.2165/00002018-199513040-00001.

Lipid formulations of amphotericin B. Less toxicity but at what economic cost?

J Tollemar¹, O Ringdén

Affiliations

PMID: 8573294
DOI: 10.2165/00002018-199513040-00001

Review

Lipid formulations of amphotericin B. Less toxicity but at what economic cost?

J Tollemar et al. Drug Saf. 1995 Oct.

. 1995 Oct;13(4):207-18.

doi: 10.2165/00002018-199513040-00001.

Authors

J Tollemar¹, O Ringdén

Affiliation

¹ Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institutet, Stockholm, Sweden.

PMID: 8573294
DOI: 10.2165/00002018-199513040-00001

No abstract available

PubMed Disclaimer

Similar articles

Amphotericin B: is a lipid-formulation gold standard feasible?
Spellberg B, Witt MD, Beck CK. Spellberg B, et al. Clin Infect Dis. 2004 Jan 15;38(2):304-5; author reply 306-7. doi: 10.1086/380844. Clin Infect Dis. 2004. PMID: 14699470 No abstract available.
Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity.
Razzaque MS, Hossain MA, Ahsan N, Taguchi T. Razzaque MS, et al. Nephron. 2001 Nov;89(3):251-4. doi: 10.1159/000046081. Nephron. 2001. PMID: 11598385 Review.
Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.
Frothingham R. Frothingham R. Clin Infect Dis. 2002 Oct 1;35(7):896-7; author reply 897-8. doi: 10.1086/342564. Clin Infect Dis. 2002. PMID: 12228830 No abstract available.
Lipid formulations of amphotericins: are you a lumper or a splitter?
Wingard JR. Wingard JR. Clin Infect Dis. 2002 Oct 1;35(7):891-5. doi: 10.1086/342563. Epub 2002 Sep 16. Clin Infect Dis. 2002. PMID: 12228829 No abstract available.
Lipid formulations of amphotericin B.
Jones E, Goldman M. Jones E, et al. Cleve Clin J Med. 1998 Sep;65(8):423-7. doi: 10.3949/ccjm.65.8.423. Cleve Clin J Med. 1998. PMID: 9769563 Review.

See all similar articles

Cited by

Bone marrow transplantation using unrelated donors for haematological malignancies.
Ringdén O. Ringdén O. Med Oncol. 1997 Mar;14(1):11-22. doi: 10.1007/BF02990940. Med Oncol. 1997. PMID: 9232606 Review.
Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in Korea.
Moeremans K, Annemans L, Ryu JS, Choe KW, Shine WS. Moeremans K, et al. Int J Hematol. 2005 Oct;82(3):251-8. doi: 10.1532/IJH97.A30504. Int J Hematol. 2005. PMID: 16207600
The cost of treating systemic fungal infections.
van Gool R. van Gool R. Drugs. 2001;61 Suppl 1:49-56. doi: 10.2165/00003495-200161001-00005. Drugs. 2001. PMID: 11219550 Review.
Advanced and controlled drug delivery systems in clinical disease management.
Brouwers JR. Brouwers JR. Pharm World Sci. 1996 Oct;18(5):153-62. doi: 10.1007/BF00820726. Pharm World Sci. 1996. PMID: 8933575 Review.
Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
Brogden RN, Goa KL, Coukell AJ. Brogden RN, et al. Drugs. 1998 Sep;56(3):365-83. doi: 10.2165/00003495-199856030-00008. Drugs. 1998. PMID: 9777313 Review.

See all "Cited by" articles

References

1. Lancet. 1994 Sep 3;344(8923):682 - PubMed
1. Leuk Lymphoma. 1992;7 Suppl:73-7 - PubMed
1. J Antimicrob Chemother. 1991 Oct;28 Suppl B:17-25 - PubMed
1. J Antimicrob Chemother. 1991 Oct;28 Suppl B:39-48 - PubMed
1. Infection. 1988 May-Jun;16(3):141-7 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information